Cardinal Health, Inc. (NYSE:CAH) Shares Acquired by GAMMA Investing LLC

GAMMA Investing LLC boosted its position in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 17,589.1% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The firm owned 964,941 shares of the company's stock after buying an additional 959,486 shares during the quarter. GAMMA Investing LLC owned approximately 0.40% of Cardinal Health worth $132,940,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Geode Capital Management LLC grew its position in Cardinal Health by 1.9% during the fourth quarter. Geode Capital Management LLC now owns 5,859,132 shares of the company's stock valued at $691,145,000 after buying an additional 109,273 shares during the period. Invesco Ltd. grew its position in Cardinal Health by 4.6% during the fourth quarter. Invesco Ltd. now owns 3,182,514 shares of the company's stock valued at $376,396,000 after buying an additional 140,368 shares during the period. Marshall Wace LLP grew its position in Cardinal Health by 154.6% during the fourth quarter. Marshall Wace LLP now owns 3,151,736 shares of the company's stock valued at $372,756,000 after buying an additional 1,913,892 shares during the period. Northern Trust Corp lifted its holdings in Cardinal Health by 16.2% during the fourth quarter. Northern Trust Corp now owns 3,037,849 shares of the company's stock valued at $359,286,000 after purchasing an additional 422,755 shares in the last quarter. Finally, UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its holdings in Cardinal Health by 4.3% during the fourth quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 2,321,797 shares of the company's stock valued at $274,599,000 after purchasing an additional 94,768 shares in the last quarter. Institutional investors and hedge funds own 87.17% of the company's stock.

Cardinal Health Trading Down 0.1%

CAH stock traded down $0.22 during trading on Thursday, reaching $153.85. 2,257,272 shares of the stock were exchanged, compared to its average volume of 2,219,923. The business has a 50 day moving average price of $143.17 and a 200-day moving average price of $131.18. Cardinal Health, Inc. has a 1 year low of $93.17 and a 1 year high of $157.82. The firm has a market capitalization of $36.72 billion, a price-to-earnings ratio of 28.70, a P/E/G ratio of 1.49 and a beta of 0.66.

Cardinal Health (NYSE:CAH - Get Free Report) last issued its earnings results on Thursday, May 1st. The company reported $2.35 EPS for the quarter, topping analysts' consensus estimates of $2.15 by $0.20. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. The company had revenue of $54.88 billion for the quarter, compared to the consensus estimate of $55.33 billion. During the same period in the previous year, the firm earned $2.08 earnings per share. Cardinal Health's quarterly revenue was up .0% compared to the same quarter last year. On average, research analysts anticipate that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, July 15th. Shareholders of record on Tuesday, July 1st will be paid a dividend of $0.5107 per share. The ex-dividend date is Tuesday, July 1st. This is an increase from Cardinal Health's previous quarterly dividend of $0.51. This represents a $2.04 dividend on an annualized basis and a yield of 1.33%. Cardinal Health's payout ratio is 31.83%.

Analyst Upgrades and Downgrades

CAH has been the topic of several recent analyst reports. Mizuho increased their price objective on shares of Cardinal Health from $142.00 to $150.00 and gave the company an "outperform" rating in a report on Monday, March 31st. Citigroup reaffirmed a "neutral" rating on shares of Cardinal Health in a report on Thursday, May 1st. Morgan Stanley increased their price objective on shares of Cardinal Health from $142.00 to $166.00 and gave the company an "overweight" rating in a report on Monday, May 5th. Jefferies Financial Group raised shares of Cardinal Health from a "hold" rating to a "buy" rating and increased their price objective for the company from $140.00 to $150.00 in a report on Wednesday, February 5th. Finally, Robert W. Baird increased their price objective on shares of Cardinal Health from $156.00 to $170.00 and gave the company an "outperform" rating in a report on Friday, May 2nd. Three analysts have rated the stock with a hold rating, eleven have given a buy rating and one has given a strong buy rating to the company's stock. According to MarketBeat, Cardinal Health has an average rating of "Moderate Buy" and an average price target of $149.50.

About Cardinal Health

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.